Aethlon Medical says shareholders reject proposal to authorize 20,000,000 preferred shares
AEMD•Aethlon Medical said shareholders rejected a proposal to authorize 20,000,000 preferred shares, with 204,122 votes in favor—below the 355,569 required—and the company’s charter was not amended.
1. Shareholder vote corrected
Aethlon Medical filed an amended 8-K to correct its earlier disclosure about a vote at the 2026 annual meeting. The proposal to authorize 20,000,000 preferred shares failed, reversing the earlier statement that it had passed; 204,122 shares voted for it, short of the 355,569 votes required.
